A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
Condition(s):Cerebrotendinous XanthomatosesLast Updated:February 15, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Cerebrotendinous XanthomatosesLast Updated:February 15, 2024Not yet recruiting
Condition(s):Cerebrotendinous XanthomatosesLast Updated:December 28, 2023Completed
Condition(s):Cerebrotendinous XanthomatosesLast Updated:August 12, 2022Completed
Condition(s):CTX – Cerebrotendinous XanthomatosisLast Updated:June 15, 2022Terminated
Condition(s):CTXLast Updated:November 22, 2023Completed
Condition(s):Xanthomatosis, CerebrotendinousLast Updated:April 1, 2021Unknown status
Condition(s):Cerebrotendinous Xanthomatosis (CTX)Last Updated:November 9, 2018Unknown status
Condition(s):Cerebrotendinous Xanthomatosis (CTX)Last Updated:June 7, 2012Unknown status
Condition(s):Hyperlipidemia; Mixed Hyperlipidemia; DyslipidemiaLast Updated:June 28, 2006Completed
Condition(s):DyslipidemiaLast Updated:August 10, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.